Maven Securities LTD Pliant Therapeutics, Inc. Transaction History

Maven Securities LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $1.4 Million - $2.72 Million	75,000 New	75,000 $2 Million
Q3 2020 Nov 13, 2020	SELL	$21.54 - $29.53 $168,012 - $230,334	-7,800 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $166,140 - $275,028	7,800 New	7,800 $253,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.